Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention

Diabetes/metabolism Research and Reviews
Revathi BalakrishnanEugenia Gianos

Abstract

Diabetes mellitus (DM) and metabolic syndrome are important targets for secondary prevention in cardiovascular disease. However, the prevalence in patients undergoing elective percutaneous coronary intervention is not well defined. We aimed to analyse the prevalence and characteristics of patients undergoing percutaneous coronary intervention with previously unrecognized prediabetes, diabetes and metabolic syndrome. Data were collected from 740 patients undergoing elective percutaneous coronary intervention between November 2010 and March 2013 at a tertiary referral center. Prevalence of DM and prediabetes was evaluated using Haemoglobin A1c (A1c ≥ 6.5% for DM, A1c 5.7-6.4% for prediabetes). A modified definition was used for metabolic syndrome [three or more of the following criteria: body mass index ≥30 kg/m2; triglycerides ≥ 150 mg/dL; high density lipoprotein <40 mg/dL in men and <50 mg/dL in women; systolic blood pressure ≥ 130 mmHg and/or diastolic ≥ 85 mmHg; and A1c ≥ 5.7% or on therapy]. Mean age was 67 years, median body mass index was 28.2 kg/m(2) and 39% had known DM. Of those without known DM, 8.3% and 58.5% met A1c criteria for DM and for prediabetes at time of percutaneous coronary intervention. Overall, 54.9% met...Continue Reading

References

Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
May 22, 2002·JAMA : the Journal of the American Medical Association·Joshua A BeckmanPeter Libby
Aug 2, 2005·The American Journal of Cardiology·Darcy Green ConawayJohn Spertus
Sep 27, 2005·Lancet·K George M M AlbertiUNKNOWN IDF Epidemiology Task Force Consensus Group
Apr 7, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·M LankischStephan Martin
Aug 22, 2006·Expert Review of Cardiovascular Therapy·D G Conaway, J H O'Keefe
Jun 8, 2007·The New England Journal of Medicine·Earl S FordSimon Capewell
Aug 19, 2007·Diabetes Care·Thomas J HoergerMichael M Engelgau
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Dec 19, 2008·The New England Journal of Medicine·William DuckworthUNKNOWN VADT Investigators
Mar 11, 2009·The American Journal of Medicine·Henry BuchwaldIsabella Sledge
Jul 31, 2009·BMC Endocrine Disorders·Ralph A DefronzoDevjit Tripathy
Mar 5, 2010·The New England Journal of Medicine·Elizabeth SelvinFrederick L Brancati
Mar 27, 2010·Journal of the American College of Cardiology·Earl S FordChaoyang Li
May 28, 2010·Diabetes Care·Kwok Leung OngBernard M Y Cheung
May 28, 2010·The New England Journal of Medicine·Giuseppe LippiGiovanni Targher
Dec 17, 2010·Circulation·Véronique L RogerUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jan 14, 2011·Diabetes Care·UNKNOWN American Diabetes Association
Mar 25, 2011·The New England Journal of Medicine·Ralph A DeFronzoUNKNOWN ACT NOW Study
Sep 17, 2013·Journal of the American College of Cardiology·Frederick A MasoudiJohn S Rumsfeld

❮ Previous
Next ❯

Citations

Mar 22, 2016·Ultrasound in Medicine & Biology·Ali-Asghar Kowsari, Ali Hosseinsabet
Feb 2, 2021·Metabolic Syndrome and Related Disorders·Luciana de Brito Gonçalves NascimentoCarla Daltro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.